Cargando…
Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review
Ulcerative colitis is the chronic relapsing multifactorial gastrointestinal inflammatory bowel disease, which is characterized by bloody or mucus diarrhea, tenesmus, bowel dystension, anemia. The annual incidence of ulcerative colitis in Asia, North America and Europe was found to be 6.3, 19.2 and 2...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908146/ https://www.ncbi.nlm.nih.gov/pubmed/27330377 http://dx.doi.org/10.1016/j.jsps.2014.10.001 |
_version_ | 1782437630767529984 |
---|---|
author | Nidhi Rashid, Muzamil Kaur, Veerpal Hallan, Supandeep Singh Sharma, Saurabh Mishra, Neeraj |
author_facet | Nidhi Rashid, Muzamil Kaur, Veerpal Hallan, Supandeep Singh Sharma, Saurabh Mishra, Neeraj |
author_sort | Nidhi |
collection | PubMed |
description | Ulcerative colitis is the chronic relapsing multifactorial gastrointestinal inflammatory bowel disease, which is characterized by bloody or mucus diarrhea, tenesmus, bowel dystension, anemia. The annual incidence of ulcerative colitis in Asia, North America and Europe was found to be 6.3, 19.2 and 24.3 per 100,000 person-years. The major challenge in the treatment of ulcerative colitis is appropriate local targeting and drug related side-effects. To overcome these challenges, microparticulate systems seem to be a promising approach for controlled and sustained drug release after oral administration. The main goal of this article is to explore the role of microparticles in ulcerative colitis for the appropriate targeting of drugs to colon. There are different approaches which have been studied over the last decade, including prodrugs, polymeric approach, time released system, pH sensitive system, which show the site specific drug delivery to colon. Among these approaches, microparticulate drug delivery system has been gaining an immense importance for local targeting of drug to colon at a controlled and sustained rate. Combined approaches such as pH dependent and time dependent system provide the maximum release of drug into colon via oral route. This article embraces briefly about pathophysiology, challenges and polymeric approaches mainly multiparticulate systems for site specific drug delivery to colon in sustained and controlled manner so that drug related side-effects by reducing dosage frequency can be minimized. |
format | Online Article Text |
id | pubmed-4908146 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-49081462016-06-21 Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review Nidhi Rashid, Muzamil Kaur, Veerpal Hallan, Supandeep Singh Sharma, Saurabh Mishra, Neeraj Saudi Pharm J Review Ulcerative colitis is the chronic relapsing multifactorial gastrointestinal inflammatory bowel disease, which is characterized by bloody or mucus diarrhea, tenesmus, bowel dystension, anemia. The annual incidence of ulcerative colitis in Asia, North America and Europe was found to be 6.3, 19.2 and 24.3 per 100,000 person-years. The major challenge in the treatment of ulcerative colitis is appropriate local targeting and drug related side-effects. To overcome these challenges, microparticulate systems seem to be a promising approach for controlled and sustained drug release after oral administration. The main goal of this article is to explore the role of microparticles in ulcerative colitis for the appropriate targeting of drugs to colon. There are different approaches which have been studied over the last decade, including prodrugs, polymeric approach, time released system, pH sensitive system, which show the site specific drug delivery to colon. Among these approaches, microparticulate drug delivery system has been gaining an immense importance for local targeting of drug to colon at a controlled and sustained rate. Combined approaches such as pH dependent and time dependent system provide the maximum release of drug into colon via oral route. This article embraces briefly about pathophysiology, challenges and polymeric approaches mainly multiparticulate systems for site specific drug delivery to colon in sustained and controlled manner so that drug related side-effects by reducing dosage frequency can be minimized. Elsevier 2016-07 2014-10-22 /pmc/articles/PMC4908146/ /pubmed/27330377 http://dx.doi.org/10.1016/j.jsps.2014.10.001 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). |
spellingShingle | Review Nidhi Rashid, Muzamil Kaur, Veerpal Hallan, Supandeep Singh Sharma, Saurabh Mishra, Neeraj Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review |
title | Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review |
title_full | Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review |
title_fullStr | Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review |
title_full_unstemmed | Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review |
title_short | Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review |
title_sort | microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: a brief review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908146/ https://www.ncbi.nlm.nih.gov/pubmed/27330377 http://dx.doi.org/10.1016/j.jsps.2014.10.001 |
work_keys_str_mv | AT nidhi microparticlesascontrolleddrugdeliverycarrierforthetreatmentofulcerativecolitisabriefreview AT rashidmuzamil microparticlesascontrolleddrugdeliverycarrierforthetreatmentofulcerativecolitisabriefreview AT kaurveerpal microparticlesascontrolleddrugdeliverycarrierforthetreatmentofulcerativecolitisabriefreview AT hallansupandeepsingh microparticlesascontrolleddrugdeliverycarrierforthetreatmentofulcerativecolitisabriefreview AT sharmasaurabh microparticlesascontrolleddrugdeliverycarrierforthetreatmentofulcerativecolitisabriefreview AT mishraneeraj microparticlesascontrolleddrugdeliverycarrierforthetreatmentofulcerativecolitisabriefreview |